Simulations Plus, Inc. (NASDAQ: SLP) said it has released version 7.0 of its best-in-class ADMET Predictor molecular property prediction software.
Dr. Robert Fraczkiewicz, team leader for ADMET Cheminformatics at Simulations Plus, said: “The release of ADMET Predictor 7.0 is the result of many months of work by our scientists and information technologies engineers along with a major collaboration with Bayer AG in Germany.”
He said the new version expands the number of predicted properties to 145.
Headquartered in Southern California, Simulations Plus is a premier developer of groundbreaking drug discovery and development simulation and modeling software, which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. Its website is at www.simulations-plus.com.